The Trump administration has restored funding for the major diabetes study. The stop is still stung

Trump administration The restoration of federal research funding at Columbia University has relaunched a historic study of diabetes that has followed patients for almost 30 years and a considerably extended understanding of the disease, its treatment and its prevention.

The study, who has been led by a professor from the Harvard Medical School since his beginning In 1996, was forced to close for almost five months after the Trump administration froze the funding of Columbia, the director of a federal subsidy distributed For research on type 2 diabetes across the country.

Scientists are jubilant on the occasion to resume their work, said David Nathan, Harvard’s researcher conducting the study on diabetes, but funding is withdrawn the last phase of research: exploration of potential ties between diabetes and dementia, including Alzheimer’s disease.